5
Participants
Start Date
April 1, 2025
Primary Completion Date
November 30, 2026
Study Completion Date
November 30, 2026
spinal cord transcutaneous stimulation
"Stimulation, using the Neostim-5 (Cosyma Ltd.), a 5-channel electrical stimulator, will be administered throughout the study period, beginning shortly after the injury and continuing at regular intervals until one year post-spinal cord injury. It will be performed in two settings:~1. During seated mapping to identify stimulation sites (potentially T7/8, T11/12, L1/2, and S1/2) and determine stimulation parameters (e.g., frequency, pulse wave, amplitude) that elevate systolic blood pressure (SBP) and maintain it within the target range of 110-120 mmHg.~2. During 70-degree tilt tests to elicit an orthostatic response (a drop in blood pressure accompanied by symptoms)."
RECRUITING
Kessler Foundation, West Orange
Lead Sponsor
Kessler Foundation
OTHER